{"id":958058,"date":"2026-05-05T07:20:31","date_gmt":"2026-05-05T11:20:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\/"},"modified":"2026-05-05T07:20:31","modified_gmt":"2026-05-05T11:20:31","slug":"arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\/","title":{"rendered":"Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW HAVEN, Conn., May  05, 2026  (GLOBE NEWSWIRE) &#8212; Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company working to create a new class of drugs based on targeted protein degradation, today announced that management will review first quarter 2026 financial results and provide a corporate update during a live webcast on Tuesday, May 12, 2026 at 8:00 a.m. ET.<\/p>\n<p>The webcast can be accessed under \u201cEvents and Presentations\u201d on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6CksN6tDOnmMoRAUPw7JxG7_-LYy8WNjmDAWg8WaT6NwS94bTL2Ht52v3fl7eniagWcygHI_b6mhsbvTqdGZQQ==\" rel=\"nofollow\" target=\"_blank\">investor page<\/a> of the Arvinas website. A replay of the webcast will be available on the Arvinas website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NPnHCA_kqntByXyQYpb8mvmxanGResvPmXpwGHZybWhfvulqlQUM_G9-1h1P1FMJEO1lSLIg3reuTgfhVK1ubQ==\" rel=\"nofollow\" target=\"_blank\">www.arvinas.com<\/a> following the completion of the event.<\/p>\n<p>\n        <strong>About\u00a0Arvinas<\/strong>\n      <\/p>\n<p>Arvinas (Nasdaq: ARVN) is a biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. Through its PROTAC (PROteolysis TArgeting Chimera) protein degrader platform, Arvinas is pioneering the development of protein degradation therapies designed to harness the body\u2019s natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas, with its partner Pfizer, developed the first-and-only U.S. Food and Drug Administration (FDA) approved PROTAC, a type of heterobifunctional protein degrader, VEPPANU (vepdegestrant), for the treatment of adults with estrogen receptor-positive (ER+)\/human epidermal growth factor receptor 2-negative (HER2-), ESR1-mutated advanced or metastatic breast cancer, as detected by an FDA-authorized test, with disease progression following at least one line of endocrine therapy.<\/p>\n<p>Arvinas is currently progressing multiple investigational drugs through clinical development programs, including ARV-102, targeting LRRK2 for neurodegenerative disorders; ARV-806, targeting KRAS G12D for mutated cancers, including pancreatic, colorectal, and non-small cell lung cancers; ARV-393, targeting BCL6 for relapsed\/refractory non-Hodgkin Lymphoma; and ARV-027, targeting the polyglutamine-expanded androgen receptor, or polyQ-AR, in skeletal muscle. Arvinas is headquartered in New Haven, Connecticut.For more information about Arvinas, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NPnHCA_kqntByXyQYpb8mm6pYJ4ivcekH1wvszcfYF8Yh27ensnSTuzydjtkY-4NrrByBXs8qKfnZkZY-AmvVg==\" rel=\"nofollow\" target=\"_blank\"><strong>www.arvinas.com<\/strong><\/a> and connect on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=13QeZO34P2yoCznmaWAnTOeff_P2ibPpxQzPzlZ1W4L33byhiG-Aaj7EpYn9rIeX6tHW4TP-21b0zmtJU16IPvtLAkZYvijciMf_PaElUsVYlgVMZl_Z5_9NcDtpgLOBTVYH34ztbI6N7r25xS5-hiXPFX7CAqP8a2PttTsJfbSKP_vfDsSDUGuxysGlrhbb4Af9Uf4y8Rlv3girmG7VkvVcMNCGsxZl2PA7uKDF4UQFXCmEVaSfNvwnrpFqjxgz\" rel=\"nofollow\" target=\"_blank\"><strong>LinkedIn<\/strong><\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oT2pT2n2IqrZXQt7-3CB1KZ6aUy3F2GqcNJVqXHHGYSBeYiO6vXyidR-pIlwaT6EIL4wdv7R1braJZzBU9I93bI9S2r0uJYurccFpZlT7c2Kg7Vq-QML61Rd9SIoxULQJjAIjgr9vXzd3L25DwygAg18M2TgWPt-s8MVTazFXeqkDfjfX3LdvaJH71013Cw3UfU64QrGv-B-KGSAf_fiFg==\" rel=\"nofollow\" target=\"_blank\"><strong>X<\/strong><\/a>.<\/p>\n<p>\n        <strong>Contacts<\/strong><br \/>\n        <br \/>\n        <strong>Investors:<\/strong><br \/>\n        <br \/>Jeff Boyle<br \/>+1 (347) 247-5089<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QF8oXjudEdTcH7eSjH6FtGthkYD9c7e6Z9NZrMHvDmg-RfpFjYbVbC7SHpdHb9nIYgh9Qs93OkJAHiMhfJ0GqOaCeasEW7cDkETOchPMODxOLMi0oAsPza59GwNm3k4LSsfRtS905s9QZKxaRY8f057HO85CkiOxNisv_p_2jKr7nscfzpDI32VJCkD8oNPO1lcFpt0e7e_3uZmyL7y9YORKhMQEc57vuHJmt1I4xn1rktc8YQ3nFr2iPM4ap8Cy1UtcVajyD0QOybFTOUG1_BjAJwJ4XyWeK_bJVI1c89SVU-QuOzLdspQuhppFbhBIjvmNbgIgJsaIHrOGPYbgXxj0u3NHsbH78T_Qt4-OQsag2aXmueIE-HDOGNdBWnkJQpLRKkANqzJySI8foypio-Y67pu_6ylvHmxUY0lEYuJ_YYOJvS-X4UVAYyVGPBBjb1kF3QZjjq_V_4DnyQmUhUovhR6UX9SSn5kvukUNkUfRYovaxsDJmytjKAd1EOH20sHO8HzCGW4asSNULuQtJ4Ldbf4CdyV7AxhN0-kUt8uaMOkGQQ3wbikKQ13euaQUKoTGDKxy7cGRxrYKOI0oWdbdoRj8VfqJmweN2IEY70KdkH6j07yxuLKBWF8cKxXGaEkngL-Zv5PO1a5JlY_2SWkHt_t1oM--OVniz-QPoRx8GBcJXUNrkgSWm0GTd9eBs3ILb9IG1LCP7SAHH1AxUScag0mlgG0RIFtc3zbyIzpKLALUnHLIa5PhcNzq89kBUW_UMffFKKzxKnIaK6mf5vLvQcMhRhyyB_aUoyc1l-8_OXBXvKy9Gazy5yHNA1wOCPtG1JmZTLjM79GARPzLJffJSdsYRdZwpdFX7GEL8FtQutU4cnawSiEXiPKNX7x94eath8H3Ahj7w_t9Q9g4xxVP_cNPyvfAZX8oWrdKvb88SI-4ujlP_E-HXXG4nWKIHxsjj0d5stIsMjdeQXTy1tyQrGn5VxGQMEuaXA7_LKEZzgGOiTG5K7AZlSW7CrlDkd8aB7GPEhfOTIdtcvXNFjNM_HBIH4sjwGs4ZsanSqsZ4krSqdIOfNddGWflj0LZJLjEPm7o3UTDHlkJdrm9T04azuFU7L6wh27k65LDgIMZwsG4_d3j-mZF_A491JYf7eBxmdUPD3KbbJxXebmxccxKFnfgGRZxugGTodrnExEVTqbTmNVAfwLCJakcn051\" rel=\"nofollow\" target=\"_blank\"><strong>Jeff.Boyle@arvinas.com<\/strong><\/a><\/p>\n<p>\n        <strong>Media:<\/strong><br \/>\n        <br \/>Alyssa Kuciunas<br \/>+1 (331) 481-3751<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_d9osul_QrkFolftpBNi9JfVIwHrNvQPbn5BB2eNm6ZSArmH-QFRzlSZ0I80StxsKhNTSqC0F3wSzJWdxRUVYusy4hlLOB3gz2RactjXw0UsPTKFhIBW7kJPbakoVA4x\" rel=\"nofollow\" target=\"_blank\"><strong>alyssa.kuciunas-c@arvinas.com<\/strong><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjc5MCM3NTgyNTA1IzIxMjIwNzY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ODRmNWRjYjctNjdkMy00ZmQ4LTg5MzktMDY0MWE3MDEyYjE5LTExMzM2NDctMjAyNi0wNS0wNS1lbg==\/tiny\/Arvinas-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW HAVEN, Conn., May 05, 2026 (GLOBE NEWSWIRE) &#8212; Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company working to create a new class of drugs based on targeted protein degradation, today announced that management will review first quarter 2026 financial results and provide a corporate update during a live webcast on Tuesday, May 12, 2026 at 8:00 a.m. ET. The webcast can be accessed under \u201cEvents and Presentations\u201d on the investor page of the Arvinas website. A replay of the webcast will be available on the Arvinas website at www.arvinas.com following the completion of the event. About\u00a0Arvinas Arvinas (Nasdaq: ARVN) is a biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. Through its PROTAC (PROteolysis &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-958058","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW HAVEN, Conn., May 05, 2026 (GLOBE NEWSWIRE) &#8212; Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company working to create a new class of drugs based on targeted protein degradation, today announced that management will review first quarter 2026 financial results and provide a corporate update during a live webcast on Tuesday, May 12, 2026 at 8:00 a.m. ET. The webcast can be accessed under \u201cEvents and Presentations\u201d on the investor page of the Arvinas website. A replay of the webcast will be available on the Arvinas website at www.arvinas.com following the completion of the event. About\u00a0Arvinas Arvinas (Nasdaq: ARVN) is a biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. Through its PROTAC (PROteolysis &hellip; Continue reading &quot;Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-05T11:20:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjc5MCM3NTgyNTA1IzIxMjIwNzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026\",\"datePublished\":\"2026-05-05T11:20:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\\\/\"},\"wordCount\":319,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMjc5MCM3NTgyNTA1IzIxMjIwNzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\\\/\",\"name\":\"Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMjc5MCM3NTgyNTA1IzIxMjIwNzY=\",\"datePublished\":\"2026-05-05T11:20:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMjc5MCM3NTgyNTA1IzIxMjIwNzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMjc5MCM3NTgyNTA1IzIxMjIwNzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\/","og_locale":"en_US","og_type":"article","og_title":"Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026 - Market Newsdesk","og_description":"NEW HAVEN, Conn., May 05, 2026 (GLOBE NEWSWIRE) &#8212; Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company working to create a new class of drugs based on targeted protein degradation, today announced that management will review first quarter 2026 financial results and provide a corporate update during a live webcast on Tuesday, May 12, 2026 at 8:00 a.m. ET. The webcast can be accessed under \u201cEvents and Presentations\u201d on the investor page of the Arvinas website. A replay of the webcast will be available on the Arvinas website at www.arvinas.com following the completion of the event. About\u00a0Arvinas Arvinas (Nasdaq: ARVN) is a biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. Through its PROTAC (PROteolysis &hellip; Continue reading \"Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-05T11:20:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjc5MCM3NTgyNTA1IzIxMjIwNzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026","datePublished":"2026-05-05T11:20:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\/"},"wordCount":319,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjc5MCM3NTgyNTA1IzIxMjIwNzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\/","name":"Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjc5MCM3NTgyNTA1IzIxMjIwNzY=","datePublished":"2026-05-05T11:20:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjc5MCM3NTgyNTA1IzIxMjIwNzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMjc5MCM3NTgyNTA1IzIxMjIwNzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/958058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=958058"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/958058\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=958058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=958058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=958058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}